Boon A J, Tans J T, Delwel E J, Egeler-Peerdeman S M, Hanlo P W, Wurzer J A, Avezaat C J, de Jong D A, Gooskens R H, Hermans J
Department of Neurology, Westeinde Hospita, The Hague, Amsterdam.
Acta Neurochir Suppl. 1998;71:331-3. doi: 10.1007/978-3-7091-6475-4_96.
The value of the measurements of CSF outflow resistance (Rcsf) relative to predicting outcome after shunting was studied. In a group of 101 patients with mainly idiopathic normal pressure hydrocephalus (NPH) Rcsf was obtained by lumbar constant flow infusion. Gait disturbance and dementia were quantified using an NPH scale (NPHS) and disability by the Modified Rankin scale (MRS). Patients were assessed before and at 1, 3, 6, 9 and 12 months after surgery. Outcome measures were differences between the preoperative and last NPHS and MRS scores. Improvement was defined as a change of > or = 15% in NPHS and > or = 1 grade in MRS. Intention-to-treat analysis of all patients at one year yielded improvement of 57% in NPHS and 59% in MRS. Efficacy analysis, excluding comorbidity unrelated to NPH, revealed positive predictive values of around 80% at Rcsf < 18, and between 90% and 100% at Rcsf > or = 18 mm Hg/ml/min. For Rcsf > or = 18, the likelihood ratios were also higher. We conclude that the best predictor of the response to shunting is an Rcsf > or = 18 mm Hg/ml/min. Since two-thirds of the patients with Rcsf < 18 showed improvement as well, these patients should not be denied shunting.
研究了脑脊液流出阻力(Rcsf)测量值对于预测分流术后结果的价值。在一组主要为特发性正常压力脑积水(NPH)的101例患者中,通过腰椎恒定流量输注获得Rcsf。使用NPH量表(NPHS)对步态障碍和痴呆进行量化,使用改良Rankin量表(MRS)对残疾程度进行量化。在手术前以及术后1、3、6、9和12个月对患者进行评估。结果指标为术前与末次NPHS和MRS评分之间的差异。改善定义为NPHS变化≥15%且MRS变化≥1级。对所有患者进行的一年意向性分析显示,NPHS改善率为57%,MRS改善率为59%。排除与NPH无关的合并症后的疗效分析显示,当Rcsf<18时,阳性预测值约为80%;当Rcsf≥18 mmHg/ml/min时,阳性预测值在90%至100%之间。对于Rcsf≥18的情况,似然比也更高。我们得出结论,对分流反应的最佳预测指标是Rcsf≥18 mmHg/ml/min。由于三分之二Rcsf<18的患者也显示出改善,因此不应拒绝为这些患者进行分流。